Lazaridou Maria, Bikiaris Dimitrios N, Lamprou Dimitrios A
Laboratory of Chemistry and Technology of Polymers and Dyes, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
Pharmaceutics. 2022 Sep 19;14(9):1978. doi: 10.3390/pharmaceutics14091978.
Bioprinting is an emerging technology with various applications in developing functional tissue constructs for the replacement of harmed or damaged tissues and simultaneously controlled drug delivery systems (DDSs) for the administration of several active substances, such as growth factors, proteins, and drug molecules. It is a novel approach that provides high reproducibility and precise control over the fabricated constructs in an automated way. An ideal bioink should possess proper mechanical, rheological, and biological properties essential to ensure proper function. Chitosan is a promising natural-derived polysaccharide to be used as ink because of its attractive properties, such as biodegradability, biocompatibility, low cost, and non-immunogenicity. This review focuses on 3D bioprinting technology for the preparation of chitosan-based hydrogel scaffolds for the regeneration of tissues delivering either cells or active substances to promote restoration.
生物打印是一项新兴技术,在开发功能性组织构建体以替代受损或损伤组织以及同时开发用于递送多种活性物质(如生长因子、蛋白质和药物分子)的可控药物递送系统(DDS)方面有多种应用。它是一种新颖的方法,能够以自动化方式对制造的构建体提供高重现性和精确控制。理想的生物墨水应具备适当的机械、流变学和生物学特性,以确保正常功能。壳聚糖是一种很有前景的天然衍生多糖,因其具有生物可降解性、生物相容性、低成本和非免疫原性等吸引人的特性而可用作墨水。本综述聚焦于用于制备基于壳聚糖的水凝胶支架的3D生物打印技术,该支架用于组织再生,可递送细胞或活性物质以促进修复。